Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenylate kinase 3 pseudogene refers to a genomic segment related in sequence to the functional adenylate kinase 3 (AK3) gene, but it is classified as a pseudogene, meaning it is generally considered nonfunctional due to mutations, truncations, or absence of critical coding potential[1][2][5]. Pseudogenes like this may arise from gene duplication or retrotransposition events and lack the ability to produce functional protein[1][5][7]. The functional AK3 gene encodes a mitochondrial enzyme involved in nucleotide metabolism, but the pseudogene does not. Some pseudogenes have emerging roles as regulatory non-coding RNAs influencing gene expression; however, there is no specific evidence that adenylate kinase 3 pseudogene plays such a role in normal physiology or disease[5][7].\n\nNote: ENSG00000270236 specifically maps to a pseudogene, not a canonical enzyme or therapeutic target[2][6][8]. For information on the functional gene, see "Adenylate kinase 3" (AK3), which is a mitochondrial phosphotransferase enzyme[2][4][9].
None (no direct drug mechanism, as pseudogene products are nonfunctional)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenylate kinase 3 pseudogene (None).